Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lackner

Showing results (111-120 of 152) with videos related to

Pageof 16
Sort By:
Neurogastroenterology and Motility|June 24, 2017
Emotional awareness and expression training improves irritable bowel syndrome: A randomized controlled trialE R Thakur, H J Holmes, N A Lockhart, et al.
Behaviour Research and Therapy|July 26, 2005
Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxietyJeffrey M Lackner, Mary Lou Coad, Howard R Mertz, et al.
Leukemia|April 6, 2016
A role for FOXO1 in BCR-ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemiaM Wagle, A M Eiring, M Wongchenko, et al.
Colloids and Surfaces. B, Biointerfaces|May 14, 2020
Patient specific implants for jawbone reconstruction after tumor resectionRoman Major, Piotr Kowalczyk, Marcin Surmiak, et al.
The Journal of Cell Biology|September 3, 2025
Telomeric SUMO level influences the choices of APB formation pathways and ALT efficiencyRongwei Zhao, Xiaoyang Yu, Tafadzwa Chigumira, et al.
Behaviour Research and Therapy|June 2, 2022
Cognitive flexibility improves in cognitive behavioral therapy for irritable bowel syndrome but not nonspecific education/supportJeffrey M Lackner, Gregory D Gudleski, Christopher D Radziwon, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 25, 2015
Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxisJ Springer, M Lackner, D Nachbaur, et al.
Behaviour Research and Therapy|December 24, 2025
Role of psychosocial factors of symptom flares in a cohort of patients with chronic urologic pelvic pain syndrome: A cognitive-affective approachJeffrey M Lackner, Yi Xiong, Andrew H Rogers, et al.
British Journal of Cancer|September 2, 2015
Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancerK O'Leary, A Shia, F Cavicchioli, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2014
Susceptibility and diversity in the therapy-refractory genus scedosporiumM Lackner, F Hagen, J F Meis, et al.
Pageof 16

Showing results (111-120 of 152) with videos related to

Sort By:
Pageof 16
Neurogastroenterology and Motility|June 24, 2017
Emotional awareness and expression training improves irritable bowel syndrome: A randomized controlled trialE R Thakur, H J Holmes, N A Lockhart, et al.
Behaviour Research and Therapy|July 26, 2005
Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxietyJeffrey M Lackner, Mary Lou Coad, Howard R Mertz, et al.
Leukemia|April 6, 2016
A role for FOXO1 in BCR-ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemiaM Wagle, A M Eiring, M Wongchenko, et al.
Colloids and Surfaces. B, Biointerfaces|May 14, 2020
Patient specific implants for jawbone reconstruction after tumor resectionRoman Major, Piotr Kowalczyk, Marcin Surmiak, et al.
The Journal of Cell Biology|September 3, 2025
Telomeric SUMO level influences the choices of APB formation pathways and ALT efficiencyRongwei Zhao, Xiaoyang Yu, Tafadzwa Chigumira, et al.
Behaviour Research and Therapy|June 2, 2022
Cognitive flexibility improves in cognitive behavioral therapy for irritable bowel syndrome but not nonspecific education/supportJeffrey M Lackner, Gregory D Gudleski, Christopher D Radziwon, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 25, 2015
Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxisJ Springer, M Lackner, D Nachbaur, et al.
Behaviour Research and Therapy|December 24, 2025
Role of psychosocial factors of symptom flares in a cohort of patients with chronic urologic pelvic pain syndrome: A cognitive-affective approachJeffrey M Lackner, Yi Xiong, Andrew H Rogers, et al.
British Journal of Cancer|September 2, 2015
Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancerK O'Leary, A Shia, F Cavicchioli, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2014
Susceptibility and diversity in the therapy-refractory genus scedosporiumM Lackner, F Hagen, J F Meis, et al.
Pageof 16